DocuSign targets unusually large options trades (NASDAQ:DOCU)
DocuSign, Inc. (NASDAQ:DOCU – Get Rating) was the target of unusually heavy options trading activity on Friday. Traders bought 52,626 call options on the stock. This represents a 32% increase from the typical volume of 39,974 call options.
Institutional entries and exits
A number of institutional investors and hedge funds have recently increased or reduced their stake in DOCU. Capital World Investors increased its equity stake in DocuSign by 128.3% in the first quarter. Capital World Investors now owns 5,683,838 shares of the company worth $608,853,000 after purchasing an additional 3,193,727 shares last quarter. Vanguard Group Inc. increased its stake in DocuSign shares by 20.3% during the first quarter. Vanguard Group Inc. now owns 17,308,877 shares of the company worth $1,854,127,000 after purchasing an additional 2,917,683 shares last quarter. Flossbach Von Storch AG increased its equity stake in DocuSign by 1,736.8% during the first quarter. Flossbach Von Storch AG now owns 2,387,867 shares of the company worth $255,788,000 after purchasing an additional 2,257,867 shares in the last quarter. Polen Capital Management LLC increased its stake in DocuSign stock by 48.5% during the first quarter. Polen Capital Management LLC now owns 5,551,792 shares of the company worth $594,708,000 after purchasing an additional 1,813,284 shares last quarter. Finally, Norges Bank purchased a new stake in DocuSign stock during the fourth quarter for a value of approximately $253,934,000. Hedge funds and other institutional investors hold 76.18% of the company’s shares.
DocuSign Stock Performance
DOCU fell $3.70 on Friday, hitting $56.58. The stock recorded a trading volume of 6,866,468 shares, compared to an average volume of 5,234,749 shares. DocuSign has a 12-month minimum of $53.25 and a 12-month maximum of $288.50. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt ratio of 1.77. The company’s 50-day moving average price is $64.22 and its two-hundred-day moving average price is $77.33. The company has a market capitalization of $11.36 billion, a P/E ratio of -104.80 and a beta of 1.23.
DocuSign (NASDAQ:DOCU – Get Rating) last released its quarterly earnings data on Thursday, September 8. The company reported earnings per share of $0.44 for the quarter, beating consensus analyst estimates of $0.42 by $0.02. DocuSign had a negative net margin of 4.65% and a negative return on equity of 21.74%. The company posted revenue of $622.18 million in the quarter, compared to $602.25 million expected by analysts. In the same quarter of the previous year, the company had earned earnings per share of ($0.07). The company’s revenue for the quarter increased 21.6% on an annual basis. Sell-side analysts expect DocuSign to post -0.45 earnings per share for the current year.
A Wall Street analyst gives his opinion
Several equity research analysts have recently commented on the stock. Piper Sandler downgraded DocuSign shares from a “neutral” rating to an “underweight” rating and lowered her price target for the stock from $65.00 to $54.00 in a research note from the Wednesday July 20. JPMorgan Chase & Co. downgraded DocuSign shares from an “underweight” to a “neutral” rating and set a price target of $65.00 for the company in a Friday 9 research note. september. Wolfe Research raised its price target on DocuSign stock from $50.00 to $53.00 and gave the stock an “underperforming” rating in a research note on Monday. Wedbush raised its price target on DocuSign shares from $50.00 to $55.00 and gave the stock an “underperforming” rating in a Friday, Sept. 9 research note. Finally, Robert W. Baird raised his price target on DocuSign shares from $60.00 to $70.00 in a Friday, September 9 report. Three equity research analysts have assigned the stock a sell rating, ten have issued a hold rating and two have assigned the stock a buy rating. According to MarketBeat.com, DocuSign currently has a consensus rating of “Hold” and an average price target of $65.75.
(Get an evaluation)
DocuSign, Inc provides electronic signature software in the United States and around the world. The company provides an e-signature solution that enables businesses to digitally prepare, sign, execute and manage agreements. It also offers CLM, which automates workflows throughout the agreement process; Information that uses artificial intelligence (AI) to research and analyze agreements by legal concepts and clauses; Gen for Salesforce, which allows sales reps to automatically generate agreements in a few clicks from Salesforce; Negotiate for Salesforce which supports approvals, document comparisons and version control; Analyzer, which helps customers understand what they’re signing before signing; and CLM+ which provide AI-powered contract lifecycle management.
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Before you consider DocuSign, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes viral…and DocuSign wasn’t on the list.
Although DocuSign currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the five actions here